Efficacy of Anifrolumab in Patients With Recalcitrant Cutaneous Lupus Erythematosus
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Rapid efficacy of anifrolumab across multiple subtypes of recalcitrant cutaneous lupus erythematosus parallels changes in discrete subsets of blood transcriptomic and cellular biomarkers
Br J Dermatol 2023 Mar 22;[EPub Ahead of Print], LM Carter, Z Wigston, P Laws, EM VitalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.